Veracyte Gets Draft Medicare Local Coverage Determination for Envisia Test

Envisia Genomic Classifier test, which uses RNA sequencing and machine learning technology to diagnose idiopathic pulmonary fibrosis.

The Wisconsin Physicians Service Insurance Corporation posted its draft LCD online and Veracyte said it anticipates that three other Medicare Administrative Contractors — CGS, Noridian Health Solutions, and Palmetto GBA — would follow suit.

Source: https://www.genomeweb.com/molecular-diagnostics/veracyte-gets-draft-medicare-local-coverage-determination-envisia-test?utm_source=Sailthru&utm_medium=email&utm_campaign=GWDN%20Fri%20AM%202018-08-31&utm_term=GW%20Daily%20News%20Bulletin